Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study
NCT06976775 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-02-18
Summary
This study investigates the efficacy and safety of two different OIT schemes to treat milk and egg allergic children
Conditions
- Food Allergy in Children
- Milk Allergy
- Egg Allergy
Interventions
- BIOLOGICAL
-
"Rush" regimen
The "rush" regimen consists of the administration of several incremental doses daily, every day, over the first week of the Induction Phase (Part 1)
- BIOLOGICAL
-
"Conventional" regimen
The "conventional" regimen consists of the administration of only one incremental dose every 2 weeks, throughout all the Induction Phase (Part 1)
Sponsors & Collaborators
-
Pablo Rodríguez del Rio
lead OTHER
Principal Investigators
-
Dr. Pablo Rodriguez del Río, MD, PhD · Hospital Infantil Niño Jesús, Instituto de Investigación La Princesa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-03
- Primary Completion
- 2027-04-30
- Completion
- 2027-04-30
Countries
- Spain
Study Locations
More Related Trials
-
Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)
NCT00537342 ·Status: COMPLETED ·Phase: PHASE3
-
Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
NCT01291381 ·Status: COMPLETED ·Phase: NA
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
Randomized Controlled Trial of Slow Multiallergen Oral Immunotherapy in Young Children
NCT06533462 ·Status: RECRUITING ·Phase: NA
-
Markers of Atopy in Children With Presumed Early Exposure to Allergens, Unhygienic Conditions, and Infections
NCT00503048 ·Status: COMPLETED
-
A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica
NCT02477917 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Anti-IgE Immunotherapy in Allergic Patients
NCT00439621 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
NCT02661854 ·Status: UNKNOWN ·Phase: PHASE2
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Sublingual Immunotherapy in Children With Allergic Rhinitis
NCT01506843 ·Status: COMPLETED ·Phase: NA
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
Management of Drug Hypersensitivity in Children
NCT02031120 ·Status: TERMINATED
-
Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
NCT03375775 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen
NCT00831025 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma
NCT05476484 ·Status: UNKNOWN
-
Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)
NCT01489020 ·Status: COMPLETED ·Phase: PHASE1
-
The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department
NCT06823154 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)
NCT01673620 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
NCT04435990 ·Status: RECRUITING ·Phase: PHASE3
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
NCT00078195 ·Status: COMPLETED ·Phase: PHASE2
-
Efficiency And Tolerance Of Hazelnut Oral Immunotherapy Protocol In Hazelnut Allergic Children
NCT04841850 ·Status: COMPLETED
-
Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense
NCT01489033 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense
NCT01567306 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica
NCT00916760 ·Status: COMPLETED ·Phase: PHASE3